The Evolution of STI Testing: A Catalyst for Modern Diagnostic Technologies
AI and Quantum Diagnostics Artificial intelligence is improving diagnostic interpretation, reducing human error and enabling early detection from standard lab data. Meanwhile, quantum and nanoscale detection technologies promise unprecedented sensitivity, pushing diagnostic precision to new frontiers. From centralized laboratories to self-testing kits, HIV diagnostics have continually redefined what’s possible when scientific innovation meets
accessibility. Each stage of this evolution, from immunoassay development to molecular integration and digital connectivity, has brought testing closer to the patient while maintaining analytical rigor. Together, emerging technologies spanning omics, nanotechnology, biosensors, CRISPR and AI are driving HIV diagnostics toward a smarter, faster and more connected future. This is essential for achieving global testing and treatment goals and ultimately ending the HIV epidemic. 16 For molecular applications, Meridian offers optimized master mixes and high-performance enzymes for qPCR, LAMP and NGS that are engineered for the sensitive detection of viral RNA and DNA, even in complex sample matrices. Our latest liquid ambient- temperature–stable formulations reduce cold-chain dependence and enable scalable deployment across both high-volume and resource-limited testing environments. By combining technical reliability with innovation, Meridian empowers assay developers to accelerate development, streamline manufacturing and ensure consistent performance across global HIV testing initiatives.
Meridian’s HIV Solutions: Enabling Accuracy Across Every Format At Meridian Life Science, we support assay developers across the full HIV diagnostics spectrum—from high-throughput laboratory systems to portable rapid tests and at-home self-testing kits.
Our immunoassay reagent portfolio includes recombinant HIV-1 and -2 antigens, paired monoclonal antibodies, and native and animal- free blockers designed to enhance signal spec- ificity and minimize background noise in CLIA, ELISA and lateral flow platforms. Each reagent is validated for lot-to-lot consistency and optimized for reliable performance across varied environmental conditions.
34 | GENengnews.com
Powered by FlippingBook